SIMPLEX TRADING, LLC - BIOCRYST PHARMACEUTICALS ownership

BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V953. A total of 3 filers reported holding BIOCRYST PHARMACEUTICALS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of BIOCRYST PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$303
+29.5%
42,800
+28.5%
0.00%
Q2 2023$234
-74.8%
33,300
-70.2%
0.00%
-100.0%
Q1 2023$930
-7.6%
111,600
+27.3%
0.00%0.0%
Q4 2022$1,006
-99.9%
87,700
+57.7%
0.00%0.0%
Q3 2022$700,000
-72.0%
55,600
-76.5%
0.00%
-66.7%
Q2 2022$2,498,000
+163.8%
236,200
+305.1%
0.00%
+200.0%
Q1 2022$947,000
-34.4%
58,300
-44.0%
0.00%0.0%
Q4 2021$1,443,000
-44.2%
104,200
-34.5%
0.00%
-50.0%
Q3 2021$2,588,000
+12.6%
159,100
+9.4%
0.00%0.0%
Q2 2021$2,298,000145,400
+8407.9%
0.00%
Q1 2021$0
-100.0%
1,709
-15.0%
0.00%
-100.0%
Q4 2020$1,498,000
+727.6%
2,011
+280.2%
0.00%
Q3 2020$181,000
+1710.0%
529
+2419.0%
0.00%
Q2 2020$10,000
+233.3%
21
+40.0%
0.00%
Q1 2020$3,000
-78.6%
15
-64.3%
0.00%
Q4 2019$14,000
+250.0%
42
+200.0%
0.00%
Q3 2019$4,000
-95.7%
14
-94.3%
0.00%
Q2 2019$93,000
+342.9%
246
+846.2%
0.00%
Q1 2019$21,000
+50.0%
26
+44.4%
0.00%
Q4 2018$14,000
+133.3%
18
-66.0%
0.00%
Q1 2018$6,000
-45.5%
53
-85.7%
0.00%
Q3 2017$11,000
-87.5%
371
-42.7%
0.00%
-100.0%
Q2 2017$88,000
+2833.3%
648
+752.6%
0.00%
Q1 2017$3,000
-90.0%
76
-42.0%
0.00%
-100.0%
Q4 2016$30,000
+1400.0%
131
+147.2%
0.00%
Q3 2016$2,000
+100.0%
53
+2550.0%
0.00%
Q2 2016$1,000
-66.7%
2
-66.7%
0.00%
Q1 2016$3,000
+200.0%
6
-72.7%
0.00%
Q4 2015$1,000
-80.0%
22
-52.2%
0.00%
Q3 2015$5,00046
+283.3%
0.00%
Q2 2015$0
-100.0%
12
+33.3%
0.00%
Q1 2015$1,000
-93.3%
9
-96.4%
0.00%
-100.0%
Q4 2014$15,0002490.00%
Other shareholders
BIOCRYST PHARMACEUTICALS shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 332,500$2,477,0000.00%
SIMPLEX TRADING, LLC 2,011$1,498,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOCRYST PHARMACEUTICALS shareholders